GlassScriptPhysician profile
Kellie N Johnson
NPI 1396975553
$890.84
in general payments reported to CMS, 2019-2025
12 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $188 · 2022: $234 · 2023: $110 · 2024: $200 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $228.30 | 2021-2024 | |
| Bausch & Lomb Americas INC. | $138.22 | 2023-2025 | Xiidra, Vyzulta, Miebo |
| Novartis Pharmaceuticals Corporation | $122.84 | 2022-2024 | |
| Abbott Laboratories | $92.32 | 2021-2025 | Amplatzer Amulet |
| Janssen Pharmaceuticals, INC | $70.25 | 2021-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $69.00 | 2021-2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.69 | 2021-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.71 | 2021-2024 | Jardiance |
| Chiesi USA, INC. | $26.20 | 2024 | Kengreal, Cleviprex |
| Impulse Dynamics (USA) INC. | $24.68 | 2024 | Optimizer |
| Medtronic, INC. | $23.80 | 2025 | Corevalve Evolut R |
| Astrazeneca Pharmaceuticals LP | $12.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.